{"entity":{"id":"nct07541430","kind":"trial","name":"A Study in Adults With Desmoid Tumors","aka":[],"tldr":"A phase 2 trial of ES014 in desmoid tumour, run by Elpiscience (Suzhou) Biopharma, Ltd., now recruiting.","summary":"A Study in Adults With Desmoid Tumors is a phase 2 interventional study registered as NCT07541430 by Elpiscience (Suzhou) Biopharma, Ltd., with 50 participants planned, started 2026-04-30 and due to reach its primary completion in 2028-01. Interventions recorded: ES014.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07541430","url":"https://clinicaltrials.gov/study/NCT07541430"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["desmoid-tumour"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07541430","phase":"2","setting":"An Open-Label, Multicenter, Single-Arm Phase 2 Study of ES014 in Adult Subjects With Desmoid Tumors","sponsor":"Elpiscience (Suzhou) Biopharma, Ltd.","enrolled":50,"outcomes":[]},"route":"/trials/nct07541430/","neighbours":{"cancer":[{"id":"desmoid-tumour","kind":"cancer","name":"Desmoid tumour","route":"/cancers/desmoid-tumour/"}]}}